Dr. Janice Faulknor is a 15-year veteran in clinical research on CNS products, Human Abuse Potential (HAP) and Abuse Deterrent Assessment programs. Having conducted over 100+ Phase1/HAL trials over her 8-year tenure as PI/Sub-I with BioPharma Services, Dr. Faulknor is an industry leader, and a key member of the BPSI medical team. Dr. Faulknor gained her medical degree from the McMaster University in 1996 with a specialty in Family Medicine and continues to practise today.
Recent Posts
- FDA Concludes Successful Inspection of BioPharma Services, Recognizing Excellence in Quality and Safety Following Comprehensive Review
- BioPharma Services Announces Expansion into Late-Stage Patient Trials and Integration with HEALWELL’s Artificial Intelligence Platform Capabilities to become a Full-Service Next Generation CRO
- Risk Management in Clinical Trials: The Sub-Investigators Role in Protecting Sponsor Investments
- Understanding Flip-Flop Pharmacokinetics: Challenges and Strategies in Drug Development
- Embracing Global Diversity: Celebrating Cultural Heritage in the Workplace
Recent Comments